Winthrop Partners - WNY’s GSK GSK Stock Holding History

Winthrop Partners - WNY’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$532K	Sell	9,981 -151	-1%	-$7.77K	0.36%	68
2019 Q2	$507K	Hold	10,132	–	–	0.38%	66
2019 Q1	$530K	Buy	10,132 +221	+2%	+$11K	0.41%	64
2018 Q4	$473K	Hold	9,911	–	–	0.44%	59
2018 Q3	$498K	Hold	9,911	–	–	0.4%	67
2018 Q2	$499K	Buy	9,911 +1,572	+19%	+$79.2K	0.42%	69
2018 Q1	$420K	Hold	8,339	–	–	0.32%	76
2017 Q4	$389K	Buy	+8,339	New	+$385K	0.32%	85

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Winthrop Partners - WNY's GSK Position: Q3 2019 in Review

Winthrop Partners - WNY reduced its GSK (GSK) stake by 1.5% in Q3 2019, selling an estimated $7.77K and leaving 9,981 shares worth $532K. The position accounts for 0.36% of the portfolio, ranked #68.

Winthrop Partners - WNY first reported a position in GSK in Q4 2017 and has held it in 8 quarters since. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Winthrop Partners - WNY held 9,981 shares of GSK worth $532K as of Q3 2019.
Winthrop Partners - WNY sold 151 GSK shares in Q3 2019, an estimated $7.77K.
GSK made up 0.36% of Winthrop Partners - WNY's portfolio in Q3 2019, its #68 holding.
Winthrop Partners - WNY first reported a position in GSK in Q4 2017 and has held it in 8 quarters since.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.